ScholarIQanswers from OpenAlex & ORCID
Glenn J. Bubley
ResearcherPublications, citations & collaboration network
Glenn J. Bubley is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Glenn J. Bubley have?
ScholarIQindexed works
Glenn J. Bubley has 441 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Glenn J. Bubley have?
ScholarIQcitation count
Glenn J. Bubley has 49,787 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Glenn J. Bubley?
ScholarIQh-index
Glenn J. Bubley has an h-index of 78 in OpenAlex.
What is the i10-index of Glenn J. Bubley?
ScholarIQi10-index
Glenn J. Bubley has an i10-index of 150 in OpenAlex.
What is the ORCID of Glenn J. Bubley?
ScholarIQorcid
The ORCID for Glenn J. Bubley is on the source record.
What is the OpenAlex record for Glenn J. Bubley?
ScholarIQopenalex
The OpenAlex for Glenn J. Bubley is on the source record.
What are the most-cited papers on Glenn J. Bubley?
ScholarIQmost cited works
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar B. Amin, Chris Andry, Matti Annala, Armen Aprikian, Joshua Armenia, Arshi Arora, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Christopher E. Barbieri, Thomas Bauer, Christopher C. Benz, Alain Bergeron, Rameen Beroukhim, Mario Berríos, Adrian Bivol, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Rodolfo Borges dos Reis, Paul C. Boutros, Jay Bowen, Reanne Bowlby, Jeffrey M. Boyd, Robert K. Bradley, Anne Breggia, Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn J. Bubley, Eric Burks, Yaron S.N. Butterfield, M. Button, David Canes, Carlos Gilberto Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard W. Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet E. Cowan, Daniel Crain, Erin Curley, Kerstin A. David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre A. Doueik, Bettina F. Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen J. Freedland, Yao Fu, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
Glenn J. Bubley, Michael A. Carducci, William L. Dahut, Nancy A. Dawson, Danai Daliani, Mario A. Eisenberger, William D. Figg, Boris Freidlin, Susan Halabi, Gary R. Hudes, Maha Hussain, Richard Kaplan, Charles E. Myers, William Oh, Daniel P. Petrylak, Eddie Reed, Bruce J. Roth, Oliver Sartor, Howard I. Scher, Jonathan W. Simons, Vickie Sinibaldi, Eric J. Small, Matthew R. Smith, Donald L. Trump, Robin T. Vollmer, George Wilding